MASH WITH FIBROSIS
Clinical trials for MASH WITH FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MASH WITH FIBROSIS trials appear
Sign up with your email to follow new studies for MASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could stop liver scarring in its tracks
Disease control Recruiting nowThis study tests an experimental drug called efruxifermin in 1650 adults with a type of liver disease (NASH/MASH) and moderate liver scarring. The goal is to see if the drug can reverse the scarring and prevent serious liver problems like liver failure or need for a transplant. P…
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
Could a common heart drug be the key to reversing fatty liver disease?
Disease control Recruiting nowThis study tests if a low dose of digoxin, a drug currently used for heart conditions, can help people with NASH (a severe type of fatty liver disease). About 144 adults with NASH and liver scarring will take oral digoxin for a period. The goal is to see if the drug can reverse t…
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 19, 2026 12:00 UTC